285 related articles for article (PubMed ID: 11012093)
1. Transforming growth factor beta1 selectively regulates ferritin gene expression in malignant H-ras-transformed fibrosarcoma cell lines.
Lo J; Hurta RA
Biochem Cell Biol; 2000; 78(4):527-35. PubMed ID: 11012093
[TBL] [Abstract][Full Text] [Related]
2. Transforming growth factor beta 1 selectively regulates ornithine decarboxylase gene expression in malignant H-ras transformed fibrosarcoma cell lines.
Hurta RA; Greenberg AH; Wright JA
J Cell Physiol; 1993 Aug; 156(2):272-9. PubMed ID: 8344985
[TBL] [Abstract][Full Text] [Related]
3. Transformation by H-ras can result in aberrant regulation of ornithine decarboxylase gene expression by transforming growth factor-beta(1).
Hurta RA; Lee J; Voskas D
J Cell Biochem; 2001; 81(1):39-55. PubMed ID: 11180396
[TBL] [Abstract][Full Text] [Related]
4. Malignant transformation by H-ras results in aberrant regulation of ribonucleotide reductase gene expression by transforming growth factor-beta 1.
Hurta RA; Wright JA
J Cell Biochem; 1995 Mar; 57(3):543-56. PubMed ID: 7768988
[TBL] [Abstract][Full Text] [Related]
5. Tumour promoter mediated altered expression and regulation of ornithine decarboxylase and S-adenosylmethionine decarboxylase in H-ras-transformed fibrosarcoma cell lines.
Voskas D; Mader R; Lee J; Hurta RA
Biochem Cell Biol; 2001; 79(1):69-81. PubMed ID: 11235918
[TBL] [Abstract][Full Text] [Related]
6. Alterations in the cyclic AMP signal transduction pathway regulating ribonucleotide reductase gene expression in malignant H-ras transformed cell lines.
Hurta RA; Wright JA
J Cell Physiol; 1994 Jan; 158(1):187-97. PubMed ID: 7505277
[TBL] [Abstract][Full Text] [Related]
7. Regulation of transforming growth factor beta receptors in H-ras oncogene-transformed rat intestinal epithelial cells.
Zhao J; Buick RN
Cancer Res; 1995 Dec; 55(24):6181-8. PubMed ID: 8521411
[TBL] [Abstract][Full Text] [Related]
8. Restored expression of transforming growth factor beta type II receptor in k-ras-transformed thyroid cells, TGF beta-resistant, reverts their malignant phenotype.
Coppa A; Mincione G; Lazzereschi D; Ranieri A; Turco A; Lucignano B; Scarpa S; Ragano-Caracciolo M; Colletta G
J Cell Physiol; 1997 Aug; 172(2):200-8. PubMed ID: 9258341
[TBL] [Abstract][Full Text] [Related]
9. Characterization of newly established tumor lines from a spontaneous malignant schwannoma in F344 rats: nerve growth factor production, growth inhibition by transforming growth factor-beta1, and macrophage-like phenotype expression.
Yamate J; Yasui H; Benn SJ; Tsukamoto Y; Kuwamura M; Kumagai D; Sakuma S; LaMarre J
Acta Neuropathol; 2003 Sep; 106(3):221-33. PubMed ID: 12811582
[TBL] [Abstract][Full Text] [Related]
10. Transforming growth factor-beta 1 mediated alterations in ribonucleotide reductase gene expression in BALB/c 3T3 fibroblasts.
Hurta RA; Greenberg AH; Wright JA
J Cell Physiol; 1992 Sep; 152(3):529-35. PubMed ID: 1506411
[TBL] [Abstract][Full Text] [Related]
11. Ras- and Raf-mediated regulation of transforming growth factor beta 1 gene expression by ligands of tyrosine kinase receptors in PC12 cells.
Cosgaya JM; Aranda A
Oncogene; 1996 Jun; 12(12):2651-60. PubMed ID: 8700524
[TBL] [Abstract][Full Text] [Related]
12. Regulation of transforming growth factor alpha messenger RNA expression in a chemically transformed rat hepatic epithelial cell line by phorbol ester and hormones.
Raymond VW; Lee DC; Grisham JW; Earp HS
Cancer Res; 1989 Jul; 49(13):3608-12. PubMed ID: 2786455
[TBL] [Abstract][Full Text] [Related]
13. Transforming growth factor-beta1 activates interleukin-6 expression in prostate cancer cells through the synergistic collaboration of the Smad2, p38-NF-kappaB, JNK, and Ras signaling pathways.
Park JI; Lee MG; Cho K; Park BJ; Chae KS; Byun DS; Ryu BK; Park YK; Chi SG
Oncogene; 2003 Jul; 22(28):4314-32. PubMed ID: 12853969
[TBL] [Abstract][Full Text] [Related]
14. Differential induction of early response genes by adrenomedullin and transforming growth factor-beta1 in human lung cancer cells.
Kane S; Prentice MA; Mariano JM; Cuttitta F; Jakowlew SB
Anticancer Res; 2002; 22(3):1433-44. PubMed ID: 12168820
[TBL] [Abstract][Full Text] [Related]
15. Transforming growth factor Beta1 induction of tissue inhibitor of metalloproteinases 3 in articular chondrocytes is mediated by reactive oxygen species.
Li WQ; Qureshi HY; Liacini A; Dehnade F; Zafarullah M
Free Radic Biol Med; 2004 Jul; 37(2):196-207. PubMed ID: 15203191
[TBL] [Abstract][Full Text] [Related]
16. Loss of transforming growth factor beta 1 (TGF-beta 1)-induced growth arrest and p34cdc2 regulation in ras-transfected epithelial cells.
Longstreet M; Miller B; Howe PH
Oncogene; 1992 Aug; 7(8):1549-56. PubMed ID: 1630817
[TBL] [Abstract][Full Text] [Related]
17. Transforming growth factor-beta1 promotes invasiveness after cellular transformation with activated Ras in intestinal epithelial cells.
Fujimoto K; Sheng H; Shao J; Beauchamp RD
Exp Cell Res; 2001 Jun; 266(2):239-49. PubMed ID: 11399052
[TBL] [Abstract][Full Text] [Related]
18. Antisense targeting of c-fos transcripts inhibits serum- and TGF-beta 1-stimulated PAI-1 gene expression and directed motility in renal epithelial cells.
Kutz SM; Providence KM; Higgins PJ
Cell Motil Cytoskeleton; 2001 Mar; 48(3):163-74. PubMed ID: 11223948
[TBL] [Abstract][Full Text] [Related]
19. Upstream stimulatory factor regulates E box-dependent PAI-1 transcription in human epidermal keratinocytes.
Allen RR; Qi L; Higgins PJ
J Cell Physiol; 2005 Apr; 203(1):156-65. PubMed ID: 15372465
[TBL] [Abstract][Full Text] [Related]
20. TGF-beta1 acts as a tumor suppressor of human malignant keratinocytes independently of Smad 4 expression and ligand-induced G(1) arrest.
Paterson IC; Davies M; Stone A; Huntley S; Smith E; Pring M; Eveson JW; Robinson CM; Parkinson EK; Prime SS
Oncogene; 2002 Feb; 21(10):1616-24. PubMed ID: 11896591
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
